Research collaboration with other companies
Karolinska Institutet cooperates successfully with a number of different companies. Together we can deliver new services, products and knowledge that help improve human health.
KI and AstraZeneca have a joint translational research center for metabolic and cardiovascular diseases.
Novo Nordisk and KI cooperate in diabetes research where the focus is on developing new possible treatments for patients.
The collaboration between KI and Janssen Pharmaceuticals NV uses observational studies for understanding effects of disease and treatment.
Karolinska Institutet (KI) recently signed a frame agreement with Testa Center
The KI collaboration with Ferring at the Center for Translational Microbiome Research is focused on mapping the human microbiome in health and disease.
KI and MSD collaborate on the use of real world data to help inform future medical and clinical research, product development and economic models.
On the way to a long-term partnership between the Karolinska Institutet and Merck KGaA.
Biogen and KI has a several fruitful scientific collaborative projects together.